Veronica Sanchez Bulis's most recent trade in Lyell Immunopharma Inc was a trade of 8,750 Common Stock done . Disclosure was reported to the exchange on Feb. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | Veronica Sanchez Bulis | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 8,750 | 15,891 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Veronica Sanchez Bulis | VP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 23.12 per share. | 10 Feb 2026 | 254 | 15,637 | - | 23.1 | 5,872 | Common Stock |
| Lyell Immunopharma Inc | Veronica Sanchez Bulis | VP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 38.67 per share. | 24 Dec 2025 | 1,136 | 8,077 | - | 38.7 | 43,929 | Common Stock |
| Lyell Immunopharma Inc | Veronica Sanchez Bulis | VP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 32.32 per share. | 24 Dec 2025 | 936 | 7,141 | - | 32.3 | 30,252 | Common Stock |
| Lyell Immunopharma Inc | Veronica Sanchez Bulis | VP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 16.10 per share. | 10 Nov 2025 | 239 | 9,213 | - | 16.1 | 3,848 | Common Stock |